AFT Pharmaceuticals Limited (NZE:AFT)

AFT Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, AFT Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $4.65. The average 1-year stock price forecast is 18.93% higher than the current stock price, while the lowest is $4.25 (+8.70%) and the highest is $5.05 (+29.16%).

Price Target: $4.65 (+18.93%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.25	$4.65	$4.65	$5.05
Change	+8.70%	+18.93%	+18.93%	+29.16%

Analyst Ratings

The average analyst rating for AFT Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Nov '25	Jan '26	Mar '26	Apr '26	May '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Adrian Allbon Jarden	Jarden	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Mar 31, 2026

Financial Forecast

Revenue This Year

303.87M

Increased by 19.30%

from 254.71M

Revenue Next Year

345.33M

Increased by 13.64%

from 303.87M

EPS This Year

0.19

Increased by 34.25%

from 0.14

EPS Next Year

0.24

Increased by 26.02%

from 0.19

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	130.31M	156.64M	195.41M	208.02M	254.71M	303.87M
Revenue Growth	15.22%	20.20%	24.75%	6.45%	22.44%	19.30%
Gross Profit	61.78M	72.98M	88.27M	91.71M	110.55M	135.22M
Gross Margin	47.40%	46.59%	45.17%	44.09%	43.40%	44.50%
Operating Income	20.39M	19.67M	24.24M	17.65M	24.45M	30.66M
Net Income	19.85M	10.65M	15.61M	11.96M	14.73M	19.71M
EPS	-	-	-	-	0.14	0.19
EPS Growth	-	-	-	-	27.27%	34.25%
Forward PE	18.43	19.12	19.41	16.79	18.37	20.80
Dividend / Share	-	0.01	0.02	0.02	0.03	0.03
Dividend Growth	-	-	45.45%	12.50%	38.89%	31.04%
Free Cash Flow	-34.75K	-4.97M	10.16M	-2.35M	-20.96M	10.55M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NZD.

Revenue Forecast

Revenue	2027	2028	2029
High	304.7M
Avg	303.9M
Low	303.1M

Revenue Growth

Revenue Growth	2027	2028	2029
High	19.6%
Avg	19.3%
Low	19.0%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	0.19
Low	-

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	34.2%
Low	-

Data Sources: S&P Global Market Intelligence and TipRanks Last updated: Mar 31, 2026

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Individual analyst data is provided by TipRanks. Price targets and consensus ratings update every hour to every three days, while individual analyst data updates in near real-time.

Data Sources Report a data error